Thrombolysis for superior vena cava syndrome post bone marrow transplant: a paediatric experience

Area of Science:

• Pediatric Critical Care Medicine
• Hematology
• Transplant Immunology

Background:

• Chediak-Higashi syndrome presents complex challenges, particularly post-bone marrow transplant.
• Pulmonary embolism (PE) and superior vena cava syndrome are critical complications in pediatric patients.
• Autoimmune hemolytic anemia can precipitate thrombotic events in immunocompromised individuals.

Purpose of the Study:

• To report a rare case of PE and SVC syndrome in a pediatric bone marrow transplant recipient.
• To highlight the successful application of catheter-directed thrombolysis in this high-risk population.
• To emphasize the importance of timely diagnosis and multidisciplinary management.

Main Methods:

• Diagnosis of PE and SVC syndrome using advanced imaging techniques.
• Management with catheter-directed tissue-type Plasminogen activator (tPA) thrombolysis.
• Close monitoring in a pediatric critical care setting.

Main Results:

• Successful resolution of PE and SVC syndrome without complications.
• Positive clinical outcome with good immune reconstitution 3 years post-transplant.
• Demonstration of tPA thrombolysis as a safe and effective treatment option.

Conclusions:

• Timely diagnosis and prompt management are crucial for pediatric patients with PE and SVC syndrome.
• Catheter-directed tPA thrombolysis is a viable and safe therapeutic option in selected pediatric cases.
• Successful bone marrow transplantation and management of complications can lead to long-term positive outcomes.